[Form 4] Argan, Inc Insider Trading Activity

Rhea-AI Filing Summary

Argan, Inc. (AGX) – Form 4 Insider Transaction Summary

Director Peter W. Getsinger reported three transactions involving the company’s common stock:

• Sale: On 26 Jun 2025, he sold 3,456 shares in the open market at $212.01 per share, generating roughly $732.7 thousand in proceeds.
• Gift to Donor-Advised Fund: On 30 Jun 2025, he transferred 1,000 shares at no consideration to a donor-advised fund managed by Martha’s Vineyard Investment Advisors.
• Family Gift: On the same date, he gifted 999 shares (333 shares each) to his three children.

Following these transactions, Getsinger’s direct beneficial ownership declined from 18,351 to 12,896 shares, a 29.7 % reduction. No derivative securities were reported.

The filing does not indicate that the sale was executed under a Rule 10b5-1 trading plan. Investors often view sizeable insider sales—particularly absent a preset plan—as a potential negative sentiment signal, although philanthropic gifts may be neutral with respect to corporate outlook.

Insights

Securities Analyst

TL;DR – Director sold ~$733k of AGX, cutting stake by ~30 %; modest negative signal.

Getsinger’s open-market disposal of 3,456 shares at $212.01 equates to about one-fifth of his pre-sale holdings, and total dispositions (including gifts) reduce ownership by nearly a third. While a single Form 4 rarely alters fundamentals, insider sales outside a 10b5-1 plan can suggest lowered personal conviction or liquidity needs. The remaining 12,896-share stake still aligns him with shareholders, but the magnitude and timing deserve monitoring, especially if additional sales follow. Because the gifts were non-cash transfers, they do not convey valuation sentiment but further reduce alignment. Overall impact: slightly negative.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Getsinger Peter W

(Last) (First) (Middle)

35 SNOWS POINT

(Street)

EDGARTOWN MA 02539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2025		S		3,456(1)	D	$212.01	14,895	D
Common Stock	06/30/2025		G		1,000(2)	D	$0	13,895	D
Common Stock	06/30/2025		G		999(3)	D	$0	12,896	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 26, 2025, the Reporting Person sold 3,456 shares of the Issuer's common stock on the open market at a price of $212.01 per share.

2. On June 30, 2025, the Reporting Person transferred 1,00 shares of the Issuer's common stock to a donor advised fund managed by Martha's Vineyard Investment Advisors.

3. On June 30, 2025, the Reporting Person gifted 333 shares to each of his three children.

	/s/ Peter W. Getsinger	06/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AGX shares did Director Peter W. Getsinger sell?

He sold 3,456 shares on 26 Jun 2025.

At what price were the AGX shares sold?

The shares were sold at $212.01 per share.

What is the director’s remaining AGX ownership after the transactions?

Getsinger now directly owns 12,896 shares of Argan, Inc.

Were any shares donated or gifted in this Form 4?

Yes, 1,000 shares were donated to a donor-advised fund and 999 shares were gifted to his three children.

Was the sale executed under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was conducted under a Rule 10b5-1 plan.